Develops, manufactures and distributes vaccines and other pharmaceutical products
GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.
It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.
The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.
The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.
The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.
The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Vote Quantity Float Company-owned shares Total Float
Shareholders GlaxoSmithKline plc (GSK - London Stock Exchange) GlaxoSmithKline plc (GSK - Nyse)
Name Equities % BlackRock Investment Management (UK) Ltd. 199,772,316
4.10% Legal & General Investment Management Ltd. 149,809,659
3.07% The Vanguard Group, Inc. 116,803,851
2.40% Capital Research & Management Co. (Global Investors) 102,630,000
2.11% Norges Bank Investment Management 92,641,000
1.90% State Street Global Advisors Ltd. 61,837,101
1.27% Aberdeen Asset Investments Ltd. 60,048,162
1.23% Threadneedle Asset Management Ltd. 59,691,735
1.23% GlaxoSmithKline Employee Trust 52,734,605
1.08% Woodford Investment Management LLP 52,369,825
Name Equities % Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,234,379 6.19% 763,751,810 USD Innoviva Inc (INVA) 32,005,260 28.3% 411,907,696 USD Theravance Biopharma Inc (TBPH) 9,644,807 20.3% 246,039,027 USD GlaxoSmithKline S.A.E. 76,161,378 91.2% 95,716,573 USD Dong-A Socio Holdings Co Ltd (000640) 409,693 8.46% 59,982,726 USD GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 555,081,926 46.4% 32,178,099 USD Oncomed Pharmaceuticals Inc (OMED) 2,607,546 8.61% 31,629,533 USD Allergy Therapeutics plc (AGY) 10,118,000 1.72% 2,535,571 USD NeuroSearch A/S (NEUR) 1,950,500 7.94% 782,970 USD Response Genetics, Inc. (RGDXQ) 5,000,000 12.9% 10,000 USD
GlaxoSmithKline plc : Connections
The Council for Industry & Higher Education
European Federation of Pharmaceutical Industries & Assns
National Theatre of Scotland
The Institute of International Finance, Inc.
Biotechnology Innovation Organization
International Institute for Management Development
International AIDS Vaccine Initiative, Inc.
United Way of Greater Philadelphia & Southern New Jersey
Longwood Fund Management LLC
Credit Suisse Americas Foundation
The Natural History Museum
French Academy of Sciences
Harvey Nichols Group Ltd.
World Presidents' Organization
Business Council for Britain
The First Tee of Greater Houston
The University of Nottingham
Rockefeller Family Trust, Inc.
Zurich Chamber of Commerce
American Academy of Arts & Sciences
Institute International d'Etudes Bancaires
Massachusetts Institute of Technology
IMD Scholarship Foundation
Pharmaceutical Research & Manufacturers of America
Swiss Bankers Association
Indian School of Business
European Financial Services Round Table
United Kingdom Department for Business, Innovation & Skills
Glaxosmithkline Australia Pty Ltd.
World Golf Foundation, Inc.
Indian Institute of Management
The Indus Entrepreneurs (Delhi)
United Way of Greater Houston
Clayton Dubilier & Rice LLP
Company contact information 980 Great West road TW8 9GS Brentford, Greater London United Kingdom Phone : +44 (0)20 8047 5000 Fax : +44 (0)20 8047 7807 Internet : http://www.gsk.com
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
- ISIN Code :
- Bloomberg Code :
- Reuters Code :
- Datastream Code :
© 2016 People , Fundamentals and Ownership
© 2016 Cofisem